Coronavirus: Can Companies Achieve Vaccine Ambition?
J&J Best Placed To Accelerate Timelines
You may also be interested in...
The UK firm speaks about its efforts to tackle the virus as a recent spike in COVID-19 cases outside China heighten concerns.
Sanofi follows Janssen in teaming up with HHS' BARDA to develop a COVID-19 vaccine; using technology platform of its Flublok vaccine, Sanofi expects to enter clinical trials in 1 to 1 ½ years.
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.